Despite countless reports showing that the Trump endorsed drug hydroxychloroquine is a massive success, far-left actor Alyssa Milano wants President Trump impeached for promoting the drug, citing a conspiracy theory that the President will profit off of it.
“Trump can make history as the first President to be impeached twice. I mean, if putting lives in danger by pushing a drug for personal gain during a pandemic isn’t impeachable, we should just throw in the towel,” she said.
Milano was reacting to an extremely misleading report where the New York Times alleged that President Trump may profit off of the drug because he owns stock in pharmaceutical companies. What they failed to mention was that the stock may be worth as little as $99.
“Mr. Trump may ultimately be right, and physicians report anecdotal evidence that has provided hope,” the Times admitted before misleading their readers.
“If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president,” the Times says adding that President Trump has “a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.”
That “small personal financial interest” may be as low as $99, practically nothing to President Trump.
Check out what MarketWatch found:
The report doesn’t say how small, but it notes that his three family trusts have investments in a Dodge & Cox mutual fund whose largest holding is Sanofi. A fund that matches this description is the Dodge & Cox International Stock Fund DODFX, +5.81%, which at last check was 3.3% invested in Sanofi.
Trump’s 2019 financial-disclosure form lists stakes in Family Trusts 1, 2 and 3 valued at between $1,001 and $15,000. So if Trump has the maximum $15,000 in each of the trusts, he holds a stake in Sanofi that’s worth $1,485 — and, at the minimum, just $99.
It turns out he does look to have more than that modest sum invested in Sanofi, because, unmentioned in the Times report, his trusts also hold broader European stock-market index funds.
MarketWatch also stated that President Trump “has a small stake in basically every big company you can think of” so therefore he would basically “benefit” from anything good happening anywhere.
Check out what Breitbart’s John Carney had to say:
The report cited by the HuffPost is from a New York Times story that said: “Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.”
Trump’s personal financial interest, however, does not include a stake in Sanofi–and the New York Times did not claim it did. Instead, Trump’s financial disclosures show that his three family trusts each had investments in a $10.3 billion Dodge & Cox mutual fund that owns shares in Sanofi, the world’s fifth-largest drugmaker by prescription sales. As of its latest disclosures, those holdings amount to just 3.3 percent of the fund’s holdings.
Trump’s most recent financial disclosure forms lists holdings in the Dodge & Cox International Fund valued between $1,001 and $15,000. That means Trump holds a maximum stake in the mutual funds of $45,000, giving him an indirect interest in Sanofi of $1,485 at the most.
His “financial interest” in Sanofi, which has a market capitalization of nearly $58 billion, could be as low as $99.10.
Journalist Mike Cernovich also pointed out how bogus the report was.
“According to Trump’s financial disclosure, he owns between $1,000 – $15,000 of Dodge & Cox fund. Dox & Cox’s fund has 2.9% of its money in Sanofi. Trump owns 2.9% of btw $1,000 – $15,000. Trump owns $29 to $435 of stock,” Cernovich said. “lol NYT didn’t think anyone would do the math.”
What are your thoughts? Let us know in the comments below!